Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 674.95

+3.1%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tommysdad who wrote (503)	1/14/2001 2:42:11 PM
From: Miljenko Zuanic	Read Replies (1) of 3557

<<This is why I personally do not attribute high potential to any programs targetting these proteins: there seem to be too many of them and there is a lot of cross-talk. >> Indeed Tom, indeed. I agree. Still, there must be master-key protein(s) which control function of this 87 feeding peptides, positive and negative regulation of the energy expenditure. Leptin? Something else? Also, market is so huge that even 5% will generate multiple $MM in sales. Sibutramine work marginally, but sell as true drug??? Do not know which bios or pharmas, but someone will get rich from this field. Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next